Study finds health professionals, public unprepared for genomic medicine

Although advances in genomic medicine for common adult chronic diseases such as heart disease, diabetes, and cancer hold promise for improved prevention, diagnosis and treatment, health professionals and the public are not prepared to effectively integrate these new tools into practice, according to a study released today by researchers from the Department of Veterans Affairs and the RAND Corporation.

Physicians and patients are optimistic about the health benefits that genetic testing might provide, but neither group is well informed about genetics and there are likely too few experts available to meet growing demands for genetic testing, according to the study in the March 19 edition of the Journal of the American Medical Association.

“Genetic testing increasingly will be available to aid in the diagnosis, prevention and treatment of common chronic diseases, not just rare genetic diseases,” said Dr. Maren Scheuner, lead author of the study and a natural scientist at RAND, a nonprofit research organization. “What requires attention now is how we will provide these services to an increasing number of patients.”

Researchers say the findings demonstrate a need for a large-scale effort to educate both health professionals and the public about genomic medicine, and to develop and evaluate new ways to deliver genetic services.

Researchers from RAND Health and the Department of Veterans Affairs reviewed all studies published from January 2000 to February 2008 about the delivery of genomic medicine for common chronic diseases. The authors synthesized the findings from 68 relevant studies to develop a picture of the status of the delivery of genomic medicine in developed countries to diagnose, prevent and treat common chronic adult illnesses.

The studies consistently found that primary care physicians feel “woefully underprepared” to integrate genetics into their practice. This includes having neither the time nor the skill necessary to obtain and interpret family histories that might detect disease patterns that merit a referral for genetic testing or specialty consultation.

“Primary care clinicians are on the front lines of patient care and they are going to need to be prepared to incorporate genetics into their practices,” Scheuner said. “Training and educating the healthcare workforce about the role of genetics in their clinical practice and increasing the size of the genetics specialty workforce are potential solutions to barriers we identified.”

While consumers report having unclear notions about the value of genetic testing for common chronic diseases, they were interested in the prospect that the tests might help identify those people who are at greater risk for chronic illnesses that are preventable.

However, consumers are worried about the prospect of adverse consequences to genetic testing -- particularly loss of privacy and discrimination by health insurers or employers among those found to be predisposed to disease, according to the study. Despite this concern, researchers found there have been no well-documented cases of health insurers asking for or using presymptomatic genetic test results to define eligibility for coverage.

Researchers also found little research describing health outcomes associated with genetic testing for common chronic diseases. Most of the research to date has focused on patients’ well-being after genetic testing, not on whether the testing prevented disease, changed treatment or extended lives. Well-designed studies that evaluate impacts on death and illness will be necessary to estimate the value that genetic tests add to health services delivery.

Researchers also found that scant research has been done to determine what might be the best system for providing genetic services for chronic adult illnesses.

Several studies in the United Kingdom found that using a nurse geneticist incorporated into a primary care practice resulted in high patient satisfaction and lower costs since fewer people required referral to a genetics specialist. But more research is needed about both the organization and the cost of systems to expand use of genetic medicine, according to researchers.

The study outlines several promising electronic tools that may offer benefits, including genetic consultation done via videoconference, disclosing genetic test results via telephone, and imbedding clinical support tools for physicians in electronic health records.

Researchers also found that most medical geneticists believe that there are too few trained specialists to adequately provide genetic services and that most directors of genetic laboratories support creation of more rigorous national standards for genetic tests to ensure quality of such testing.

Source: RAND Corporation

Related stories:

New electrostatic-based DNA microarray technique could revolutionize medical diagnostics
The dream of personalized medicine — in which diagnostics, risk predictions and treatment decisions are based on a patient's genetic profile — may be on the verge of being expanded beyond the wealthiest of nations with state-of-the-art clinics.
Predicting the risk of a common fungal infection after stem cell transplantation
In silico genetic analysis in mice has led to the discovery of a gene affecting susceptibility to a severe fungal infection in transplant recipients. In a study published June 20th in the open-access journal PLoS Genetics, investigators from Duke University Medical Center, the National Institute of Environmental Health Sciences, Roche Palo Alto, the Fred Hutchinson Cancer Research Center, and the National Jewish Medical and Research Center found that genetic variation within the plasminogen gene in mice and men affects susceptibility to a severe and life-threatening fungal infection.
Same drug, different results: MUHC researcher on the path to personalized medicine
Minor genetic differences between individuals change the effect of a common medication, study shows
Medicine has moved a little bit closer to the era of tailor-made treatments, based on the unique genetic profiles of individual patients, according to recent research conducted by Dr Rima Rozen of the Research Institute of the McGill University Health Centre (RI MUHC) at the Montreal Children's Hospital and McGill University. Her study, published June 18 in the journal Pharmacogenetics and Genomics, shows how minor genetic differences between individuals alter the way a common drug affects the body.

Perspective: Policies must keep pace with genetic progress
Enactment of the Genetic Information Nondiscrimination Act (GINA) of 2008 is a boon to individual patients and for genetic research, write Kathy Hudson, M.K. Holohan, and Francis Collins in the June 19 issue of the New England Journal of Medicine. But the bill is not a panacea, they note: Employers, health insurers, patients, and doctors now must be educated about its provisions, gaps remain in genetic testing oversight, and there still may be opportunities to misuse genetic information.
Researchers discover traits of aggressive form of prostate cancer
Researchers led by a team at the Michigan Center for Translational Pathology at the University of Michigan Health System have identified traits of an aggressive type of prostate cancer that occurs in about 10 percent of men who have the disease. They hope the discovery could lead, possibly within the next few years, to a simple urine test that will help to diagnose this variation of prostate cancer.
Lost in translation: Language barrier adds confusion to prenatal testing
Many people struggle to understand the complexities of genetic problems in pregnancy and find medical language difficult to understand, particularly when faced with major decisions such as whether to terminate a pregnancy. A recent study, funded by the Economic and Social Research Council (ESRC), investigated how Britain's Bangladeshi community understand the disorders, and make decisions about testing and screening in the light of health care and religious opinion.
Researchers find human virus in chimpanzees
After studying chimpanzees in the wilds of Tanzania's Mahale Mountains National Park for the past year as part of a National Science Foundation (NSF) grant, Virginia Tech researcher Dr. Taranjit Kaur and her team have produced powerful scientific evidence that chimpanzees are becoming sick from viral infectious diseases they have likely contracted from humans.
Earthworm detectives provide genetic clues for dealing with soil pollution
The humble earthworm, famously acknowledged by Charles Darwin when he wrote "It may be doubted whether there are many other animals... which have played so important a part in the history of the world", provides a new sensitive and detailed picture of what is going on in our contaminated soil ecosystems.

News discussion:

Medicine & Health news